MDS-PAS Congress 2026 Session Evaluation - Session 2104

  • MDS-PAS Congress 2026 Session 2104 Evaluation Form

  • Plenary Session 2104

    Novel Clinical Trials in Movement Disorders

    February 14, 2026

    10:45 - 12:30

  • Learning Objectives:

    1. Review the state-of-the-art of Phase 3 clinical trials in Parkinson´s disease targeting management of motor and non-motor symptoms as well as motor fluctuations
    2. Review the progress of clinical trials for disease-modifying therapies targeting cohorts in atypical parkinsonisms
    3. Describe advances in clinical trials for essential tremor

  • Session Evaluation

  • The session met its learning objectives
  • The content is relevant to my professional and / or scientific interests.
  • The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.
  • The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.
  • The overall session organization was satisfactory and appropriate.
  • I would recommend this session to a colleague.

  • Faculty Assessment

  • Oscar Gershanik

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Anne-Marie Wills

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • William Ondo

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.
  • The following category best describes your current major professional activity (choose one):

  • Should be Empty: